KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Kyverna Therapeutics, Inc. to Contact the Firm Today! ...

Levi & Korsinsky Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - KYTX ...

NEW YORK, Jan. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to Kyverna’s initial public offering conducted on February 8, 2024 (the “IPO”), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

Group 1 - The article announces a deadline for joining a class action lawsuit against Kyverna Therapeutics, Inc. (KYTX) [1] - The deadline to join the class action is set for February 7, 2025 [1] - The lawsuit pertains to potential grievances related to Kyverna Therapeutics, Inc. [1]

Core Viewpoint - Kyverna Therapeutics, Inc. is facing a lawsuit for alleged violations of securities laws, which may impact investors and their interests [1] Group 1 - The lawsuit is being pursued by the Schall Law Firm, indicating potential legal ramifications for the company [1] - Investors affected by the alleged violations are encouraged to reach out to the law firm for assistance [1]

Group 1 - The article discusses a class action lawsuit involving Kyverna Therapeutics, Inc. and highlights the opportunity for shareholders to take action [1] - The law firm Bronstein, Gewirtz and Grossman, LLC is mentioned as the contact for shareholders interested in participating in the lawsuit [1] - The focus is on the potential implications for shareholders and the legal proceedings surrounding the company [1]

Group 1 - The article discusses a pending class action lawsuit against Kyverna Therapeutics, Inc. (KYTX) for shareholders who have incurred losses [1] - Shareholders are encouraged to contact the law firm Levi & Korsinsky regarding their potential claims [1] - The focus is on the financial impact on shareholders and the legal recourse available to them [1]

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - KYTX ...

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics Inc. ...

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX).Shareholders who purchased shares of KYTX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/kyverna-therapeutics-inc-loss-submission-form/?id=123047&from=4CLASS PERIOD: T ...